ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
File(s)
Accepted version
Author(s)
Type
Journal Article
Abstract
The development of guidelines is one of the core activities of the European Society for Medical Oncology (ESMO) and European Society of Gynaecologial Oncology (ESGO), as part of the mission of both societies to improve the quality of care for patients with cancer across Europe. ESMO and ESGO jointly developed clinically-relevant and evidence-based guidelines in several selected areas in order to improve the quality of care for women with ovarian cancer. The ESMO-ESGO consensus conference on ovarian cancer was held on 12-14 April 2018 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of ovarian cancer. Before the conference, the expert panel worked on five clinically relevant questions regarding ovarian cancer relating to each of the following four areas: pathology and molecular biology, early-stage and borderline tumours, advanced stage disease and recurrent disease. Relevant scientific literature, as identified using a systematic search, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. The recommendations presented here are thus based on the best available evidence and expert agreement. This article presents the recommendations of this ESMO-ESGO consensus conference, together with a summary of evidence supporting each recommendation.
Date Issued
2019-05-07
Date Acceptance
2019-02-25
Citation
International Journal of Gynecological Cancer, 2019, 29 (4), pp.728-760
ISSN
1048-891X
Publisher
BMJ Publishing Group
Start Page
728
End Page
760
Journal / Book Title
International Journal of Gynecological Cancer
Volume
29
Issue
4
Copyright Statement
© 2019 The Author(s). This article has been accepted for publication in International Journal of Gynecological Cancer following peer review. The definitive copyedited, typeset version Colombo N, Sessa C, Bois AD on behalf of the ESMO–ESGO Ovarian Cancer Consensus Conference Working Group, et alESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseaseInternational Journal of Gynecologic Cancer 2019;29:728-760 is available online at: http://dx.doi.org/10.1136/ijgc-2019-000308.
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
Obstetrics & Gynecology
GRADE SEROUS CARCINOMA
RANDOMIZED PHASE-III
PLATINUM-BASED CHEMOTHERAPY
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
ADVANCED EPITHELIAL OVARIAN
CLEAR-CELL-CARCINOMA
TERM-FOLLOW-UP
FERTILITY-SPARING SURGERY
PATIENT-REPORTED OUTCOMES
PRIMARY SITE ASSIGNMENT
adjuvant treatment
molecular biology
ovarian cancer
pathology
recurrent disease
surgery
ESMO–ESGO Ovarian Cancer Consensus Conference Working Group
Oncology & Carcinogenesis
1112 Oncology and Carcinogenesis
Publication Status
Published
Date Publish Online
2019-05-02